GLP-1 Agonists Show Lower Diabetes, CV Risk Than Metformin in Prediabetes | Retatrutide News

GLP-1 agonists reduce diabetes and cardiovascular risk more effectively than metformin in prediabetes. This could influence the development and applicat...
Clinical Trials · November 5, 2026